ST Pharm Co.Ltd (237690) — Cash Flow-to-Debt Ratio
ST Pharm Co.Ltd (237690) has a Cash Flow-to-Debt Ratio of -0.11x as of December 2025, meaning its operating cash flow of ₩-21.16 Billion could theoretically repay 0% of its total liabilities (₩189.56 Billion) in one year. Explore how much of ST Pharm Co.Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ST Pharm Co.Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for ST Pharm Co.Ltd across 11 annual periods. Also explore how large is ST Pharm Co.Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for ST Pharm Co.Ltd (2015–2025)
Year-by-year debt coverage analysis for ST Pharm Co.Ltd. For market capitalisation and broader financial context, see 237690 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | ₩13.99 Billion | ₩189.56 Billion | ▼ -85.2% |
| 2024 | 0.50x | ₩109.45 Billion | ₩218.88 Billion | ▲ +11012.0% |
| 2023 | 0.00x | ₩1.30 Billion | ₩288.53 Billion | ▼ -85.1% |
| 2022 | 0.03x | ₩7.03 Billion | ₩233.02 Billion | ▼ -27.1% |
| 2021 | 0.04x | ₩7.27 Billion | ₩175.59 Billion | ▲ +129.7% |
| 2020 | -0.14x | ₩-20.93 Billion | ₩150.24 Billion | ▲ +81.7% |
| 2019 | -0.76x | ₩-30.52 Billion | ₩40.12 Billion | ▼ -198.4% |
| 2018 | 0.77x | ₩10.77 Billion | ₩13.94 Billion | ▼ -56.8% |
| 2017 | 1.79x | ₩54.44 Billion | ₩30.42 Billion | ▲ +92.2% |
| 2016 | 0.93x | ₩50.78 Billion | ₩54.53 Billion | ▲ +173.0% |
| 2015 | 0.34x | ₩35.82 Billion | ₩105.04 Billion | — |